U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
AMEDIPLASE
T2A562QTPQ
Investigational
General
Names
5
Identifiers
10
Subunits
1
Related Substances
1
AMEDIPLASE
T2A562QTPQ
Investigational
General
Approval Year
Unknown
149,124
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
AMEDIPLASE
Official Name
English
173-L-SERINE-174-L-TYROSINE-175-L-GLUTAMINE-173-275-PLASMINOGEN ACTIVATOR (HUMAN TISSUE-TYPE REDUCED), FUSION PROTEIN WITH UROKINASE (HUMAN URINE B-CHAIN REDUCED)
Preferred Name
English
AMEDIPLASE [MI]
Common Name
English
amediplase [INN]
Common Name
English
Amediplase [WHO-DD]
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
EVMPD
SUB33209
PRIMARY
MERCK INDEX
m1655
PRIMARY
Merck Index
NCI_THESAURUS
C169777
PRIMARY
PUBCHEM
154656
PRIMARY
INN
7732
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
1
Related Substances
1
SUBSTANCE RECORD
T2A562QTPQ
AMEDIPLASE
